|
S.N. Nedvetskaya, V.G. Tregubov, I.Z. Shubitidze, M.V. Tregubova
Influence of angiotensin-converting enzyme inhibitors on the structural and functional parameters of the heart and subjective parameters of the quality of life of patients with essential hypertension
|
№1-2 / 2023
|
|
O.D. Ostroumova (1, 2), A.I. Kochetkov (1), V.V. Vikentyev (1), E.E. Pavleyeva (1)
POSSIBILITIES OF AMLODIPINE/LISINOPRIL FIXED-DOSE COMBINATION IN REAL CLINICAL PRACTICE
|
№15 / 2017
|
|
O.D. Ostroumova (1, 2), A.I. Kochetkov (1), M.V. Lopukhina (3), V.V. Vikent’yev (1), A.G. Abrosimov (2)
ALGORITHM OF THE SELECTION OF ANTIHYPERTENSIVE THERAPY AGAINST THE INVOLVEMENT OF HEART AS A TARGET ORGAN IN ARTERIAL HYPERTENSION
|
№9 / 2017
|
|
O. D. Ostroumova, T.F.Gusev, I.V.Hvorostyany
Blood Pressure Variability – New Target For Stroke Prevention
|
№14 / 2012
|
|
Fomin V.V., Pulin A.A., Saginova E.A.
Diabetic Nephropathy: Does Angiotensin-converting Enzyme Inhibitors Maintain Priority Position?
|
№3 / 2011
|
|
Shevchenko A.O., Dvoryankova E.V., Shevchenko O.P., Shilova U.V.
Comparison Of Efficiency And Safety Of Co-diroton, Enalapril And Hydrochlorothiazide In Psoriatic Patients With Arterial Hypertension And Overweight
|
№20 / 2010
|
|
L. Minushkina
Lisinopril In The Treatment Of Arterial Hypertension In Patients With Concomitant Liver Pathology
|
№5 / 2010
|
|
A.I. Martinov
Arterial Hypertension: Importance Of Individual Drugs Selection And Place Of Angiotensin-converting Enzyme Inhibitors In The Treatment
|
№15 / 2009
|
|
V.N. Mineev
Peculiarities Of Differential Diagnostics And Treatment Of Arterial Hypertension In Young People
|
№15 / 2009
|
|
O.N. Korneeva
Place Of Lisinopril In The Therapy Of Cardio-vascular Complications In Patients With Metabolic Syndrome
|
№12 / 2009
|
Русский
